Recombinant Macaca maura NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

What is MT-ND4L and what is its role in mitochondrial function?

MT-ND4L (NADH dehydrogenase subunit 4L) is one of the core subunits of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), the first enzyme in the respiratory chain. This protein participates in the electron transfer process from NADH to ubiquinone, which is essential for oxidative phosphorylation and ATP production . MT-ND4L is typically encoded by the mitochondrial genome in most eukaryotes, though some organisms like Chlamydomonas reinhardtii have this gene (NUO11) in the nuclear genome . The protein is embedded within the inner mitochondrial membrane where it helps create the electrochemical gradient necessary for ATP synthesis .

How does MT-ND4L participate in Complex I assembly?

MT-ND4L plays a crucial role in the assembly of functional Complex I. Research employing RNA interference to suppress MT-ND4L (NUO11) gene expression has demonstrated that the absence of this subunit prevents the complete assembly of the 950-kDa whole Complex I and eliminates enzyme activity . MT-ND4L is likely involved in the membrane arm assembly of Complex I, which is one of two independent assembly pathways (the other being the matrix arm) . The membrane arm contains the catalytic site for the substrate ubiquinone, and MT-ND4L's hydrophobic nature suggests it has a structural role in maintaining proper membrane integration of this portion of the complex .

What experimental approaches are used to study recombinant MT-ND4L?

Several methodological approaches are employed to study recombinant MT-ND4L:

• Heterologous expression: Recombinant MT-ND4L can be expressed in E. coli systems with affinity tags (typically His-tag) for purification .

• Protein purification: After expression, the protein is typically purified using affinity chromatography, utilizing the His-tag for selective binding to metal chelate resins.

• Structural characterization: Techniques including circular dichroism spectroscopy, NMR spectroscopy, and crystallography approaches can be used to analyze protein structure.

• Functional assays: NADH oxidation assays, ubiquinone reduction measurements, and electron transfer kinetics can evaluate the protein's activity within reconstituted systems .

• Protein-protein interaction studies: Cross-linking experiments, co-immunoprecipitation, and yeast two-hybrid systems help identify interaction partners within Complex I.

How do mutations in MT-ND4L affect Complex I function and what are the implications for disease pathology?

Mutations in MT-ND4L can significantly impact Complex I function with important disease implications. For example, the rare MT-ND4L variant rs28709356 (C>T) has been associated with increased risk of Alzheimer's disease in a study analyzing the Alzheimer's Disease Sequencing Project data (p = 7.3 × 10^-5) . This suggests MT-ND4L may play a role in neurodegenerative processes.

The mechanistic impact of MT-ND4L mutations can be understood through:

• Electron transfer disruption: Mutations may alter the protein's ability to facilitate electron movement from NADH to ubiquinone.

• Complex I assembly failure: As demonstrated in RNA interference studies, without functional MT-ND4L, the entire 950-kDa complex fails to assemble properly .

• ROS production alterations: Dysfunction in Complex I is known to affect reactive oxygen species generation, potentially contributing to oxidative stress and cellular damage .

• Mitochondrial membrane potential changes: Disruptions in Complex I function can alter the electrochemical gradient across the inner mitochondrial membrane, affecting ATP production capacity .

Researchers investigating these phenomena typically employ site-directed mutagenesis of recombinant MT-ND4L followed by functional reconstitution assays to measure the specific effects of mutations on electron transfer rates, complex stability, and ROS production.

What are the technical challenges in working with recombinant MT-ND4L and how can they be overcome?

Working with recombinant MT-ND4L presents several technical challenges due to its highly hydrophobic nature and membrane protein characteristics:

• Protein solubility issues: The hydrophobic nature of MT-ND4L makes it prone to aggregation during expression and purification. This can be addressed by:

  • Using specialized detergents (LDAO, DDM, or Triton X-100) during purification

  • Employing fusion partners like MBP (maltose-binding protein) to enhance solubility

  • Optimizing buffer conditions with glycerol or specific salt concentrations

• Proper folding: Ensuring correct folding of recombinant MT-ND4L requires:

  • Temperature optimization during expression (typically lower temperatures of 16-20°C)

  • Co-expression with chaperone proteins

  • Using membrane-mimetic environments during purification and storage

• Functional reconstitution: For activity studies, the protein must be incorporated into systems mimicking the native environment:

  • Reconstitution into liposomes or nanodiscs containing appropriate lipid compositions

  • Co-reconstitution with other Complex I subunits to form partial or complete complexes

• Protein stability: Once purified, maintaining stability requires:

  • Storage in appropriate buffer conditions (Tris/PBS-based buffer with 6% trehalose has been used successfully)

  • Addition of 5-50% glycerol for long-term storage at -20°C/-80°C

  • Avoiding repeated freeze-thaw cycles

How can researchers effectively evaluate the electron transfer properties of recombinant MT-ND4L in experimental systems?

Researchers can evaluate electron transfer properties of recombinant MT-ND4L using several methodological approaches:

• Reconstituted enzyme activity assays: Measure NADH:ubiquinone oxidoreductase activity by:

  • Monitoring NADH oxidation spectrophotometrically at 340 nm

  • Tracking ubiquinone reduction at appropriate wavelengths

  • Comparing activity with and without specific inhibitors like rotenone to determine complex-specific activity

• Electron paramagnetic resonance (EPR) spectroscopy: This technique can:

  • Characterize the iron-sulfur clusters associated with the electron transport pathway

  • Monitor electron transfer through these redox centers in real-time

  • Identify specific bottlenecks in electron flow when MT-ND4L variants are tested

• Membrane potential measurements: Using:

  • Potential-sensitive fluorescent dyes in reconstituted liposome systems

  • Patch-clamp techniques with specialized membrane preparations

  • Measurements of proton translocation coupled to electron transfer

• ROS production assessment: Since Complex I dysfunction can lead to oxidative stress:

  • Measuring superoxide production using specific fluorescent probes

  • Quantifying hydrogen peroxide generation in reconstituted systems

  • Correlating electron transfer rates with ROS production

A typical experimental workflow involves:

• Reconstituting purified recombinant MT-ND4L with other Complex I components

• Establishing baseline electron transfer rates with wild-type proteins

• Comparing these rates with systems containing MT-ND4L variants or under different experimental conditions

• Analyzing data to determine kinetic parameters (Km, Vmax) and inhibitor sensitivities

How can recombinant MT-ND4L be used to investigate mitochondrial diseases?

Recombinant MT-ND4L serves as a valuable tool for investigating mitochondrial diseases through several research applications:

• Disease-associated mutation modeling: Researchers can introduce specific mutations identified in patients with mitochondrial disorders into recombinant MT-ND4L to study their functional consequences. For example, investigations similar to those performed on the ND1/3460 and ND4/11778 mutations associated with Leber hereditary optic neuropathy (LHON) could be applied to MT-ND4L variants .

• Structure-function relationship studies: By systematically altering key residues in MT-ND4L and assessing the impact on Complex I assembly and function, researchers can map critical domains and interactions within the protein.

• Drug screening platforms: Reconstituted systems containing recombinant MT-ND4L can be used to:

  • Screen for compounds that rescue function in disease-associated MT-ND4L variants

  • Identify molecules that enhance Complex I activity or reduce ROS production

  • Evaluate potential therapeutic approaches for mitochondrial disorders

• Biomarker development: Antibodies raised against recombinant MT-ND4L can be used to:

  • Detect abnormal levels or modifications of MT-ND4L in patient samples

  • Develop diagnostic tests for specific mitochondrial disorders

  • Monitor disease progression or treatment efficacy

What comparative studies between human and Macaca maura MT-ND4L provide insights into evolutionary conservation and functional significance?

Comparative studies between human and Macaca maura MT-ND4L can reveal important insights about evolutionary conservation and functional significance of this protein. The key aspects of such research include:

• Sequence alignment analysis: Sequence comparison reveals:

  • Highly conserved regions that likely serve critical functional roles

  • Species-specific variations that may reflect adaptive changes

  • Potential functional domains based on conservation patterns

• Structural comparisons: Modeling both proteins can:

  • Identify conserved structural elements essential for Complex I assembly

  • Reveal differences in transmembrane domains that might affect membrane insertion

  • Predict interaction interfaces with other Complex I subunits

• Functional substitution experiments: By replacing human MT-ND4L with Macaca maura MT-ND4L in experimental systems:

  • Researchers can determine if the primate protein can functionally substitute for its human counterpart

  • Identify species-specific differences in electron transfer efficiency or ROS production

  • Understand evolutionary constraints on Complex I function

• Disease-relevant variant analysis: Comparing the effects of equivalent mutations in both species can:

  • Reveal differential susceptibility to functional impairment

  • Provide insights into species-specific compensatory mechanisms

  • Inform the development of appropriate disease models

What is the role of MT-ND4L in oxidative stress and how can recombinant forms be used to study this relationship?

MT-ND4L, as a component of Complex I, plays a significant role in oxidative stress through several mechanisms:

Recombinant MT-ND4L can be used to study these relationships through:

• Reconstituted systems for ROS measurement:

  • Wild-type and variant forms of MT-ND4L can be compared for differences in ROS production

  • The effects of oxidative modifications on MT-ND4L structure and function can be assessed

  • Antioxidant compounds can be screened for their ability to modulate ROS production

• Oxidative modification mapping:

  • Mass spectrometry can identify specific residues in MT-ND4L susceptible to oxidative modification

  • Site-directed mutagenesis of these residues can determine their functional significance

  • The impact of various oxidative stressors on MT-ND4L can be systematically evaluated

• Interaction with antioxidant systems:

  • Co-expression systems can evaluate how MT-ND4L variants affect the induction of antioxidant responses

  • The relationship between Complex I activity and cellular antioxidant capacity can be explored

What are the optimal expression and purification protocols for recombinant Macaca maura MT-ND4L?

The optimal expression and purification protocols for recombinant Macaca maura MT-ND4L involve several key considerations:

Expression System Optimization:

• E. coli strain selection: BL21(DE3), C41(DE3), or C43(DE3) strains are preferred as they are designed for membrane protein expression .

• Expression vector design:

  • Incorporate an N-terminal His-tag for purification

  • Consider fusion partners like SUMO or MBP to enhance solubility

  • Include a precision protease cleavage site for tag removal if needed

• Culture conditions:

  • Use lower temperatures (16-18°C) during induction to reduce inclusion body formation

  • Extend induction time (16-24 hours) to allow proper folding

  • Optimize inducer concentration (typically 0.1-0.5 mM IPTG)

Purification Protocol:

• Cell lysis:

  • Use gentle lysis methods (e.g., osmotic shock or enzymatic methods)

  • Include protease inhibitors to prevent degradation

  • Maintain low temperatures throughout processing

• Membrane fraction isolation:

  • Separate membrane fraction by ultracentrifugation

  • Solubilize membranes with appropriate detergents (DDM, LDAO, or Triton X-100)

• Affinity chromatography:

  • Use Ni-NTA resins for His-tagged proteins

  • Employ imidazole gradient elution to minimize contaminants

  • Include detergent in all buffers to maintain protein solubility

• Further purification:

  • Size exclusion chromatography to separate aggregates

  • Ion exchange chromatography for additional purity

• Storage conditions:

  • Tris/PBS-based buffer containing 6% trehalose at pH 8.0

  • Addition of 5-50% glycerol for long-term storage

  • Store at -20°C/-80°C in small aliquots to avoid freeze-thaw cycles

The final purified protein should achieve >90% purity as verified by SDS-PAGE .

How can researchers effectively reconstitute functional Complex I using recombinant MT-ND4L for structural and functional studies?

Reconstituting functional Complex I using recombinant MT-ND4L requires a systematic approach:

• Component preparation:

  • Purify all necessary Complex I subunits (either individually or as subcomplexes)

  • Ensure proper folding and stability of each component

  • Verify purity and integrity using SDS-PAGE and western blotting

• Reconstitution strategies:

  • Co-expression approach: Express multiple Complex I subunits simultaneously in a suitable host

  • Step-wise assembly: Combine purified subcomplexes in a defined order mimicking the natural assembly pathway

  • Membrane scaffold approach: Use nanodiscs or liposomes to provide a membrane-like environment

• Assembly verification methods:

  • Blue Native PAGE to assess complex formation

  • Electron microscopy to visualize complex architecture

  • Cross-linking mass spectrometry to confirm subunit interactions

  • Dynamic light scattering to evaluate complex homogeneity

• Functional validation:

  • NADH oxidation assays to verify electron acceptance

  • Ubiquinone reduction measurements to confirm complete electron transfer

  • Rotenone sensitivity tests to verify specific inhibitor responses

  • Proton pumping assays to confirm coupling of electron transfer to proton translocation

• Optimizing reconstitution conditions:

  • Buffer composition (pH, salt concentration, presence of stabilizing agents)

  • Lipid composition for membrane mimetics (cardiolipin is particularly important)

  • Temperature and incubation time for assembly

  • Presence of specific cofactors (iron-sulfur clusters, FMN)

Successfully reconstituted Complex I containing MT-ND4L should display:

• NADH oxidation activity comparable to native Complex I

• Appropriate sensitivity to Complex I inhibitors

• Stable assembly as determined by analytical techniques

• Proper stoichiometry of all subunits

What advanced imaging and structural characterization techniques are most effective for studying MT-ND4L in the context of Complex I?

Several advanced imaging and structural characterization techniques are particularly effective for studying MT-ND4L within Complex I:

• Cryo-Electron Microscopy (Cryo-EM):

  • Provides high-resolution structural information without crystallization

  • Can capture different conformational states of Complex I

  • Allows visualization of MT-ND4L's position and interactions within the complex

  • Recent advances enable resolutions approaching 2-3 Å for membrane protein complexes

• Cross-linking Mass Spectrometry (XL-MS):

  • Identifies interaction interfaces between MT-ND4L and neighboring subunits

  • Captures dynamic and transient interactions

  • Can be used in combination with structural models to validate predicted interactions

  • Particularly useful for mapping assembly intermediates

• Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Measures solvent accessibility and conformational dynamics

  • Identifies regions of MT-ND4L that undergo conformational changes during catalysis

  • Can detect subtle structural changes induced by mutations or inhibitor binding

• Single-Particle Tracking and Super-Resolution Microscopy:

  • Monitors the dynamics of fluorescently labeled MT-ND4L in cellular contexts

  • Provides insights into the mobility and distribution of Complex I in membranes

  • Can be used to study assembly processes in living cells

• Electron Paramagnetic Resonance (EPR) Spectroscopy:

  • Characterizes the electronic structure of iron-sulfur clusters near MT-ND4L

  • Tracks electron transfer events through redox centers

  • Provides information about the local environment of paramagnetic centers

• Solid-State Nuclear Magnetic Resonance (ssNMR):

  • Can provide atomic-level structural information on membrane proteins

  • Particularly useful for determining dynamic regions and conformational changes

  • Allows study of the protein in a native-like membrane environment

By combining these techniques, researchers can develop a comprehensive understanding of MT-ND4L's structure, function, and dynamics within Complex I, enabling more targeted approaches to address research questions related to mitochondrial diseases and potential therapeutic interventions.

How are mutations in MT-ND4L linked to neurodegenerative diseases and what are the investigative approaches using recombinant proteins?

MT-ND4L mutations have significant implications for neurodegenerative diseases, with substantial evidence linking these genetic variants to pathological conditions:

• Alzheimer's Disease (AD) associations:

  • The rare MT-ND4L variant rs28709356 (C>T) has shown study-wide significant association with AD risk (p = 7.3 × 10^-5)

  • Gene-based tests also revealed significant association of MT-ND4L with AD (p = 6.71 × 10^-5)

  • These findings provide evidence for mitochondrial dysfunction as a contributor to AD pathogenesis

• Potential mechanisms in neurodegeneration:

  • Impaired energy production leading to neuronal vulnerability

  • Increased oxidative stress due to Complex I dysfunction

  • Altered calcium homeostasis affecting neuronal signaling

  • Compromised mitochondrial quality control

Investigative approaches using recombinant MT-ND4L include:

• Disease variant characterization:

  • Creating recombinant MT-ND4L proteins containing disease-associated mutations

  • Comparing their biochemical properties to wild-type protein

  • Measuring the impact on Complex I assembly and function

• Cellular models:

  • Introducing recombinant mutant MT-ND4L into neuronal cell models

  • Assessing mitochondrial function, morphology, and distribution

  • Measuring cellular responses like oxidative stress, apoptosis, and protein aggregation

  • Evaluating synaptic function and neuronal connectivity

• High-throughput screening applications:

  • Using purified mutant MT-ND4L in reconstituted systems to screen for compounds that restore function

  • Identifying molecules that can stabilize Complex I assembly despite MT-ND4L mutations

  • Finding agents that reduce ROS production associated with dysfunctional MT-ND4L

• Structural biology approaches:

  • Determining how disease mutations alter MT-ND4L structure

  • Identifying potential sites for targeted drug design

  • Understanding compensatory structural changes that might occur

What is the significance of MT-ND4L in aging research and how can recombinant protein studies contribute to understanding age-related mitochondrial dysfunction?

MT-ND4L plays a significant role in aging research due to its position within Complex I, which is central to both energy production and age-related mitochondrial dysfunction:

• MT-ND4L in aging processes:

  • Complex I activity typically declines with age, contributing to reduced ATP production

  • Accumulation of mutations in mitochondrial DNA, including MT-ND4L, occurs throughout aging

  • Complex I is a major source of ROS, which can damage cellular components and accelerate aging

  • Mitochondrial dysfunction is a hallmark of aging across multiple tissue types

• MT-ND4L as a model for studying mitochondrial theory of aging:

  • Allows investigation of how specific mutations affect Complex I function over time

  • Provides insights into tissue-specific vulnerabilities to mitochondrial dysfunction

  • Helps explain the progressive nature of age-related decline in energy metabolism

Recombinant protein studies can contribute to understanding age-related mitochondrial dysfunction through:

• Age-related modification analysis:

  • Studying how post-translational modifications that accumulate with age affect MT-ND4L function

  • Examining oxidative damage patterns on recombinant MT-ND4L and correlation with functional decline

  • Creating modified versions of MT-ND4L that mimic age-related changes

• Comparative studies across species with different lifespans:

  • Comparing Macaca maura MT-ND4L with homologs from short-lived and long-lived species

  • Identifying structural or functional features that correlate with longevity

  • Testing whether MT-ND4L from long-lived species confers resistance to oxidative damage

• Interventional research:

  • Screening compounds that protect MT-ND4L from age-related damage

  • Testing whether caloric restriction or exercise mimetics affect MT-ND4L function

  • Evaluating how nutritional interventions known to extend lifespan impact MT-ND4L stability

• Integration with omics approaches:

  • Correlating MT-ND4L function with age-related changes in the proteome, metabolome, and lipidome

  • Understanding how MT-ND4L interacts with other age-regulated proteins

  • Developing predictive models of mitochondrial aging based on MT-ND4L status

What methodological approaches can be used to study the potential role of MT-ND4L in cancer metabolism?

Cancer cells often exhibit altered mitochondrial function and energy metabolism, making MT-ND4L a relevant target for cancer research. The following methodological approaches can be used to study its role in cancer metabolism:

• Expression and mutation analysis in cancer tissues:

  • Comparing MT-ND4L sequence and expression levels between tumor and adjacent normal tissues

  • Correlating MT-ND4L variants with cancer progression, metastasis, and treatment response

  • Performing large-scale bioinformatic analyses across cancer databases to identify recurring patterns

• Functional studies using recombinant MT-ND4L in cancer models:

  • Introducing wild-type or cancer-associated variants of MT-ND4L into cancer cell lines

  • Measuring the impact on:

    • Oxidative phosphorylation vs. glycolytic metabolism

    • ROS production and oxidative stress responses

    • Cell proliferation, invasion, and resistance to apoptosis

    • Sensitivity to chemotherapeutic agents

• Metabolic flux analysis:

  • Using isotope-labeled substrates to trace metabolic pathways in cells with modified MT-ND4L

  • Determining how MT-ND4L variants affect nutrient utilization and metabolic reprogramming

  • Measuring oxygen consumption, extracellular acidification, and ATP production rates

• In vivo cancer models:

  • Developing xenograft or genetic models with modified MT-ND4L expression

  • Tracking tumor growth, metastasis, and response to therapy

  • Using imaging techniques to monitor tumor metabolism in real-time

• Drug discovery approaches:

  • Screening for compounds that specifically target cancer cells with MT-ND4L alterations

  • Investigating synthetic lethality between MT-ND4L dysfunction and other cancer pathways

  • Developing combination therapies that exploit cancer-specific metabolic vulnerabilities

• Clinical correlation studies:

  • Analyzing patient samples for MT-ND4L status and correlation with clinical outcomes

  • Stratifying patients based on MT-ND4L variants for personalized treatment approaches

  • Developing potential biomarkers based on MT-ND4L status or function

These methodological approaches can provide valuable insights into the role of MT-ND4L in cancer metabolism and potentially identify new therapeutic targets or strategies for cancer treatment.